3794
P. Z. Wang et al. / Tetrahedron: Asymmetry 9 (1998) 3789–3795
4.77 (dd, J=9.7, 1.3 Hz, 1H), 4.07 (dt, J=9.7, 2.5 Hz, 1H), 3.54 (ddd, J=11.5, 3.5, 2.5 Hz, 1H), 3.38 (dd,
J=8.1, 3.5 Hz, 1H), 3.27 (dd, J=8.1, 3.5 Hz, 1H), 1.90–1.07 (m, 12H), 1.01 (d, J=6.4 Hz, 6H), 1.00 (d,
J=6.4 Hz, 3H), 0.95 (d, J=6.6 Hz, 3H), 0.86, 0.88 (2d, J=6.6 Hz, 6H); 13C NMR δ 96.2, 92.2, 78.4, 78.1,
76.3, 69.7, 41.4, 38.4, 32.0, 31.4, 29.8, 29.3, 29.2, 28.7, 23.1, 22.3, 21.8, 19.0, 18.8, 18.7; EI-MS (two
isomers) m/z (%) 171 (M+−17, 8), 170 (M+−18, 13), 115 (92), 71 (100); FAB-HRMS: 171.1447, calcd
for C10H18O2+H: 171.1380.
3.8. (3R,5R,6R)-3,7-Dimethyl-5,6-dihydroxy-octanan-ethanedithiolketal 16
To a solution of 15 (200 mg, 1.06 mmol) in 5 ml CH2Cl2 were added 0.08 ml BF3·OEt2 and 1,2-
ethandithiol (0.11 ml, 1.31 mmol), and stirring was continued for 2 h at room temperature. After the
addition of water (2 ml), the mixture was extracted with CH2Cl2 (3×20 ml). The combined organic layer
was washed with brine (2×10 ml), dried over Na2SO4 and purified by column chromatography to give
25
1
16 (210 mg, 75%) as an amorphous solid. [α] =+23 (c 0.01, CHCl3); H NMR δ 4.60 (t, J=7.1 Hz,
D
1H), 3.78 (br, 1H), 3.31 (dd, J=8.1, 3.8 Hz, 1H), 3.23 (m, 4H), 2.11 (br, 2H), 1.82–1.20 (m, 6H), 1.01
(d, J=6.6 Hz, 3H), 0.97 (d, J=6.6 Hz, 3H), 0.87 (d, J=6.8 Hz, 3H); 13C NMR δ 80.2, 69.8, 51.6, 47.2,
38.3, 38.2, 36.6, 30.0, 29.5, 19.0, 18.7, 16.8; EI-MS m/z (%): 264 (M+, 6), 246 (56), 131 (59), 105 (100);
FAB-HRMS: 264.1200, calcd for C12H24S2O2: 264.1212.
3.9. (3R,5R,6R)-3,7-Dimethyl-5,6-acetonide-octanan-ethanedithiolketal 5
To a solution of 16 (55 mg, 0.208 mmol) in 2 ml dry acetone was added a catalytic amount of PTS. The
mixture was stood for 1 day at room temperature, and was then diluted with ether (20 ml) and washed with
saturated NaHCO3 solution (3×5 ml) and brine (2×5 ml), dried over Na2SO4 and purified by column
chromatography to give 5 as a yellowish oil (50 mg, 79%). [α]25=+69 (c 0.01, CHCl3); 1H NMR δ 4.51
D
(t, J=7.4 Hz, 1H), 4.05 (ddd, J=11.6, 5.0, 2.4 Hz, 1H), 3.59 (dd, J=9.8, 5.0 Hz, 1H), 3.08–3.21 (m, 4H),
1.61–1.87 (br, 1H), 1.55–1.75 (m, 5H), 1.39 (s, 3H), 1.27 (s, 3H), 0.96 (d, J=6.6 Hz, 3H), 0.92 (d, J=6.6
Hz, 3H), 0.78 (d, J=6.6 Hz, 3H); 13C NMR δ 18.7, 19.0, 20.4, 26.2, 28.8, 27.3, 29.2, 35.8, 38.3, 38.3,
47.5, 51.5, 74.9, 83.9, 107.5; EI-MS m/z (%) 304 (M+, 15), 289 (43), 145 (64), 105 (100); FAB-HRMS:
305.1544, calcd for C15H28O2S2+H: 305.1602.
3.10. (3R,5R)-2-Isopropyl-3-t-butylchlorodimethoxy-5-methyl-cyclohexene 17
To a solution of 10 (730 mg, 4.74 mmol) in 2 ml dry DMF were added imidazole (717 mg, 11.8 mmol)
and tert-butyldimethylsilyl chloride (857 mg, 5.7 mmol). The mixture was stirred at room temperature
for 2 h, then diluted with ether (100 ml), washed successively with water (2×20 ml) and brine (2×20
ml), dried over Na2SO4 and concentrated to give 17 (1.14 g, 95%) as a colorless oil. 1H NMR δ 5.50 (br,
1H), 4.18 (br, 1H), 2.34–1.25 (m, 6H), 1.08 (d, J=6.0 Hz, 3H), 1.00 (d, J=6.6 Hz, 3H), 0.94 (d, J=6.0
Hz, 3H), 0.92 (s, 9H), 0.12 (s, 6H).
3.11. (3R,5R)-3,7-Dimethyl-5-t-butylchlorodimethoxy-6-oxo-octanal 18
Following the same procedure as 12, the compound 17 (1.34 g, 5.0 mmol) gave 18 (1.38 g, 92%) as a
1
colorless oil. H NMR δ 9.72 (t, J=1.8 Hz, 1H), 4.20 (dd, J=7.8, 5.2 Hz, 1H), 3.01 (m, 1H), 2.33–1.45
(m, 5H), 1.08 (d, J=6.9 Hz, 3H), 1.04 (d, J=6.9 Hz, 3H), 0.94 (d, J=6.9 Hz, 3H), 0.92 (s, 9H), 0.05 (s,
6H).